Creo Medical Group PLC Share Price

Equities

CREO

GB00BZ1BLL44

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 09:05:16 31/05/2024 pm IST 5-day change 1st Jan Change
36.5 GBX +3.55% Intraday chart for Creo Medical Group PLC +3.55% -20.65%

Financials

Sales 2023 30.8M 39.22M 3.27B Sales 2024 * 40.37M 51.41M 4.29B Capitalization 127M 162M 13.52B
Net income 2023 -21M -26.74M -2.23B Net income 2024 * -14M -17.83M -1.49B EV / Sales 2023 5.2 x
Net cash position 2023 * 22.03M 28.05M 2.34B Net cash position 2024 * 132K 168K 14.03M EV / Sales 2024 * 3.15 x
P/E ratio 2023
-6.57 x
P/E ratio 2024 *
-9.36 x
Employees 279
Yield 2023 *
-
Yield 2024 *
-
Free-Float 79.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.55%
1 week+3.55%
1 month+2.10%
3 months+17.74%
6 months+12.31%
Current year-20.65%
More quotes
1 week
35.00
Extreme 35
36.90
1 month
32.00
Extreme 32
37.00
Current year
29.12
Extreme 29.12
50.00
1 year
22.72
Extreme 22.718
50.00
3 years
19.00
Extreme 19
220.00
5 years
19.00
Extreme 19
243.00
10 years
19.00
Extreme 19
250.00
More quotes
Managers TitleAgeSince
Founder - -
Chief Executive Officer - 01/12/01
President - -
Members of the board TitleAgeSince
Chairman 59 01/16/01
Director/Board Member 60 -
Chief Executive Officer - 01/12/01
More insiders
Date Price Change Volume
31/24/31 36.5 +3.55% 1,296,494
30/24/30 35.25 -.--% 229,773
29/24/29 35.25 -.--% 220,118
28/24/28 35.25 -.--% 741,956
24/24/24 35.25 -.--% 284,428

Delayed Quote London S.E., May 31, 2024 at 09:05 pm IST

More quotes
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.365 GBP
Average target price
0.895 GBP
Spread / Average Target
+145.21%
Consensus

Annual profits - Rate of surprise